Atera’s Business Intelligence Unveils its MSPs are Becoming More Profitable and Efficient
Mar 06, 2018 13:01 pm UTC| Business
ORLANDO, Fla., March 06, 2018 -- Atera, developer of the big data-based IT automation platform that combines Remote Monitoring and Management (RMM), Professional Services Automation (PSA), and remote access into one...
Optimal IdM Awarded USF Fast 56
Mar 06, 2018 13:01 pm UTC| Business
TAMPA, Fla., March 06, 2018 -- Optimal IdM, a leading provider of Identity and Access Management (IAM) solutions, today announced it has been awarded the USF Fast 56. The Fast 56 identifies, recognizes and celebrates...
Altimmune to Participate at Two Investor Conferences in March
Mar 06, 2018 13:01 pm UTC| Business
GAITHERSBURG, Md., March 06, 2018 -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, announced today that Bill Enright, President and Chief Executive Officer, will provide a corporate overview...
Granite Gold® Makes Stone Care Easy at The Home Depot
Mar 06, 2018 13:01 pm UTC| Business
SAN DIEGO, March 06, 2018 -- Clean, seal and polish are the three essential steps to maintain granite and other natural-stone surfaces, and they are all now available nationwide at The Home Depot. ...
Sack Lunch Announces Qualification Date for Regulation A+ Offering
Mar 06, 2018 13:01 pm UTC| Business
SALT LAKE CITY, March 06, 2018 -- Sack Lunch Productions, Inc. (OTCMKTS:SAKL) an action oriented event company announced today that its Regulation A+ Offering will be qualified as of March 2, 2018. The Offering Circular...
Foamix Pharmaceuticals to Present at the Cowen & Company 38th Annual Health Care Conference
Mar 06, 2018 13:01 pm UTC| Business
REHOVOT, Israel, and BRIDGEWATER, N.J., March 06, 2018 -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), (“Foamix”), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary...
CymaBay to Report Fourth Quarter and Fiscal Year 2017 Financial Results on Thursday, March 15
Mar 06, 2018 13:00 pm UTC| Business
NEWARK, Calif., March 06, 2018 -- CymaBay Therapeutics, Inc. (Nasdaq:CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, today...
Johannesburg in a time of darkness: Ivan Vladislavić’s new memoir reminds us of the city’s fragility
Economist Chris Richardson on an ‘ugly’ inflation result and the coming budget
Biden administration tells employers to stop shackling workers with ‘noncompete agreements’
IceCube researchers detect a rare type of energetic neutrino sent from powerful astronomical objects